To cope with changing environmental conditions, eukaryotic cells employ various stress pathways designed to maintain or restore homeostasis in a given compartment or in response to a particular need. Stress pathways may also be invoked during development, when cells adapt their machineries and reset their homeostatic balances to befit the novel physiological role(s) they are bound to assume. A striking example of this is the differentiation of B cells into antibody-secreting plasma cells. When suitably activated, B cells abandon their quiescent state and undergo an extensive metamorphosis to become -in a matter of few days -one of the most prolific secretory cells [1]. A profound "makeover" is required, that most notably results in a massively expanded endoplasmic reticulum (ER), the organelle where antibodies fold, assemble and are subjected to stringent quality control before proceeding along the exocytic pathway for eventual secretion [1,2].That a signaling pathway is responsible for adjusting the folding capacity of the ER according to necessity was first hypothesized in the late 1980s/early 1990s [3,4], and then proven to indeed exist through genetic screens in yeast [5,6]. Using drugs that perturb productive protein folding specifically in the ER Correspondence: Dr. Eelco van Anken e-mail: eelco.vananken@hsr.it by targeting N-linked glycosylation or disulfide bond formation, the key components of the so-called unfolded protein response (UPR) were identified. Biochemical analyses demonstrated that Ire1 is a transmembrane protein with a stress-sensing domain in the ER and a bifunctional kinase/endonuclease effector domain in the cytosol [7,8]. Intriguingly, the endonuclease domain of Ire1 is dedicated to the excision of an intron from the HAC1 mRNA [7,8]. Upon spliceosome-independent intron removal and religation of the severed exons by Rlg1 [9], the processed HAC1 mRNA encodes a transcription factor that drives the expression of a vast repertoire of chaperones, folding assistants, and other factors needed for the expansion of a functional ER [10].A major breakthrough came when XBP-1 was identified as the mammalian equivalent of yeast HAC1 mRNA, likewise undergoing IRE1α-mediated nonconventional splicing [11][12][13]. Thus, the Ire1/IRE1α-HAC1/XBP-1 axis of the UPR is conserved from yeast to human. These findings, combined with the seminal discovery that XBP-1 is essential for plasma cell differentiation [14], revealed that the IRE1α/XBP-1 relay is central to the development of cells that commit to a professional secretory phenotype [14,15]. Moreover, B-cell activation entails the induction of the transcription factor Blimp-1 [16], which represses BSAP/Pax5 [17,18]. Since BSAP/Pax5 represses XBP-1 [19], the net result is that XBP-1 transcription is enhanced in activated B cells [20]. Altogether,www.eji-journal.eu
642Eelco van Anken et al. Eur. J. Immunol. 2014. 44: 641-645 connecting the dots between the requirements for high antibody production and UPR signaling highlights how findings from fields as di...